(HealthDay)—For women who have ductal carcinoma in situ surgically removed, a genetic test may help predict the odds of a recurrence, according to research presented at the annual San Antonio Breast Cancer ...
Dec 14, 2014
2 / 5 (1) | 0
Adding ovarian suppression to tamoxifen reduced recurrence for some women with premenopausal breast cancer
Among premenopausal women with early-stage, hormone receptor-positive breast cancer, adding ovarian suppression to tamoxifen reduced breast cancer recurrence for those who had previously received chemotherapy and remained ...
Dec 12, 2014
5 / 5 (1) | 0